Future shows great potential for neurological language assessments in clinical trials.
Jessica Robin
Advertisement
Director of Clinical Research, Winterlight Labs
Articles by Jessica Robin
Advertisement
Latest Updated Articles
How Speech-Based Digital Biomarkers are Redefining the Measurement of Disease Progression in Neurodegenerative Dementia TrialsPublished: March 15th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
2025 SCRS Global Site Solutions Summit: How to Streamline Site Qualification and Initiation Training
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
